It is interesting that previous studies that investigated the same biomarkers presented slightly different results, reporting the significant difference in NfL, GFAP, and TAU levels between survivors and deceased severe COVID-19 patients, but they did not observe the same to UCH-L1 levels [12, 28]. The gene discussed is UCHL1; the disease is COVID-19.